THEA INTAL: Open Payments
NPI 1093596744 · BELLEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 27 payments from 11 companies in 2025. Trend: 2023 $22 · 2024 $244 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $124 |
| Xeris Pharmaceuticals, Inc. | 4 | $62 |
| Novo Nordisk Inc | 3 | $56 |
| ABBVIE INC. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Corcept Therapeutics | 2 | $28 |
| Insulet Corporation | 1 | $24 |
| Medtronic, Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $18 |
Products named: JARDIANCE, MOUNJARO, GVOKE HYPOPEN, SYNTHROID, Wegovy, Korlym, Omnipod, MINIMED 780G.
Industry payments across NJ — which companies pay providers there.
